A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools

2015 ◽  
Vol 22 (5) ◽  
pp. 785-799 ◽  
Author(s):  
Matthew N.T. Thuy ◽  
Jeremy K.T. Kam ◽  
Geoffrey C.Y. Lee ◽  
Peter L. Tao ◽  
Dorothy Q. Ling ◽  
...  
Phytomedicine ◽  
2021 ◽  
pp. 153533
Author(s):  
Ismini Kyriakou ◽  
Niousha Yarandi ◽  
Elena Polycarpou

2021 ◽  
Vol 22 (10) ◽  
pp. 3075-3080
Author(s):  
Jellyca Anton ◽  
Sudibio Sudibio ◽  
Handoko Handoko ◽  
Tiara Permata ◽  
Henry Kodrat ◽  
...  

2011 ◽  
Vol 12 (11) ◽  
pp. 1062-1070 ◽  
Author(s):  
Pieter L Kubben ◽  
Karlien J ter Meulen ◽  
Olaf EMG Schijns ◽  
Mariël P ter Laak-Poort ◽  
Jacobus J van Overbeeke ◽  
...  

2021 ◽  
Vol 25 (1) ◽  
pp. 108
Author(s):  
Gideon Adegboyega ◽  
Ulrick Sidney Kanmounye ◽  
Tatjana Petrinic ◽  
Ahmad Ozair ◽  
Soham Bandyopadhyay ◽  
...  

Pathogens ◽  
2020 ◽  
Vol 9 (8) ◽  
pp. 661
Author(s):  
Juana P. Correa ◽  
Antonella Bacigalupo ◽  
Esteban Yefi-Quinteros ◽  
Gemma Rojo ◽  
Aldo Solari ◽  
...  

We present a review on the natural infection by trypanosomatids of nonhuman vertebrates in Chile, aiming to synthesize and update the knowledge on the diversity of trypanosomatids infecting native and alien vertebrate species. To this end, we conducted a systematic review of literature records published from 1900 to April 2020 on four databases, focusing on the 21 genera of trypanosomatids and Chile. The methods and findings of our review have been based on the preferred reporting items for systematic reviews and meta-analysis (prisma) checklist. We found 29,756 records but only 71 presented relevant information for this review. Overall, there are only two reported trypanosomatid genera infecting vertebrate species in Chile, the genera Trypanosoma and Leishmania. The former is mostly represented by Trypanosoma cruzi (90% of the total records) and to a much lesser extent by Trypanosoma avium, Trypanosoma humboldti, Trypanosoma lewisi, and a couple of unidentified trypanosomatids. A total of 25 mammals have been reported as being infected by T. cruzi, including 14 native and 11 alien species from Orders Artiodactyla, Carnivora, Chiroptera, Didelphimorphia, Lagomorpha, Perissodactyla, and Rodentia. Extensive screening studies using new analytical tools are necessary to grasp the whole potential diversity of trypanosomatid species infecting vertebrates in Chile.


2018 ◽  
Vol 91 (1088) ◽  
pp. 20170271 ◽  
Author(s):  
Asmaa Almadani ◽  
Sanjay Dixit ◽  
Chris Rowland-hill ◽  
Shailendra Achawal ◽  
Chitoor Rajaraman ◽  
...  

2021 ◽  
Author(s):  
Sarfraz Akmal ◽  
Elizabeth E. Ginalis ◽  
Nitesh V. Patel ◽  
Robert Aiken ◽  
Simon J. Hanft

Abstract Introduction: Glioblastoma is an aggressive cancer with a notoriously poor prognosis. Recent advances in treatment have increased overall survival, though this may be accompanied by an increased incidence of leptomeningeal disease (LMD). LMD carries a particularly severe prognosis and remains a late stage manifestation of glioblastoma without satisfactory treatment. The objective of this review is to survey the literature on treatment of LMD in glioblastoma and to more fully characterize the current therapeutic strategies. Methods: The authors performed a systematic review following PRISMA criteria on PubMed. Articles that included adult patients with LMD from glioblastoma multiforme were retrieved and reviewed. Results: LMD in glioblastoma patients is increasing in incidence, with reports of up to 21%. The overall survival without treatment is alarmingly brief, with patients surviving between 1.6-3.8 months. All studies showed that treatment does improve overall survival significantly, increasing to 11.7 months in one study. However, no one adjuvant or surgical therapy has been shown to improve survival in LMD significantly over another. Direct treatment methods include chemotherapy (standard, anti-angiogenic, intrathecal, immunotherapy), and radiation. Hydrocephalus is a complication in LMD that can be treated with ventriculoperitoneal shunt placement, however treating hydrocephalus and delivering intrathecal chemotherapy is a challenge. Conclusion: Though evidence remains lacking and there is no consensus, treatments show a trend towards improving survival and should be considered on a case-by-case basis. Further studies are necessary in the pursuit of a standard of care.


Sign in / Sign up

Export Citation Format

Share Document